Talcum Powder Litigation Report
Hot on the heels of separate $72 million and $55 million verdicts entered against Johnson & Johnson defendants, HarrisMartin has launched this Talcum Powder Litigation Report, an online-only resource dedicated solely to news on talc-based powder ovarian cancer claims.
SEARCH THE ARCHIVES
Issue #05, August 2016
A petition to create a coordinated docket for California’s growing number of talcum powder claims has been granted, according to a recent ruling.
At least nine new talcum powder exposure lawsuits have been filed in federal courts across the country in recent days, with the plaintiffs in each one contending that they developed ovarian cancer as a result of using Baby Powder and Shower-to-Shower.
A New Jersey state court is currently overseeing hearings related to expert admissibility in two talcum powder lawsuits, one of which is set to begin trial this fall, sources told HarrisMartin.
Defendants Oppose Remand Efforts in Multi-Plaintiff Talcum Powder Suit, Say Courts Don’t Have Personal Jurisdiction over Non-Resident Manufacturers
Defendants named in a New Mexico talcum powder lawsuit have opposed the plaintiffs’ remand efforts, maintaining that “courts do not possess personal jurisdiction over non-resident manufacturers as to claims by out-of-state plaintiffs that arose out of state.”
Plaintiffs whose talcum powder claims were recently removed to federal court have asked that court to stay the proceedings, arguing that they have recently moved to remand and continuing before the court has a chance to rule on that motion would save time and judicial resources.
Two new talcum powder lawsuits were filed recently in Alabama and Georgia federal courts, with each one of the plaintiffs contending that they developed ovarian cancer as a result of using Johnson & Johnson’s products.
Plaintiffs in a class action talcum powder lawsuit filed two years ago in California have asked the federal court overseeing the lawsuit to stay the proceeding in light of the recent motion to create a coordinated docket for the pending talc-based powder product litigation.
Plaintiffs involved in a class action lawsuit pending in Illinois federal court have indicated that they intend to oppose the recent motion to create a multi-district litigation docket for talcum powder claims.
A hospital in control of a talcum powder plaintiff’s pathology slides and tissue blocks has indicated that it will not release the original pathology slides or tissue blocks without a court order, according to a status report from the plaintiff.
Issue #04, July 2016
Plaintiffs with claims pending in New Mexico’s federal court have moved to remand the case, maintaining that there is no basis for the court to exercise jurisdiction over the claims.